関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
単一のレジオネラエフェクタによって媒介されるフォスフォリボシル-ユビキチン化のメカニズム
Anil Akturk1, David J Wasilko1, Xiaochun Wu1
1Weill Institute for Cell and Molecular Biology and Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Nature
|May 26, 2018
まとめ
研究者らは,新しいフォスフォリボシル関連ユビキチン化メカニズムを明らかにした. このユニークな翻訳後の改変は,SdeAがウビキチンをセルリン結合のためにフォスフォリボシルウビキチン (PR-Ub) に処理することを含む.
科学分野:
- 生物化学
- 分子生物学
- 構造生物学
背景:
- ユビキチネーションは,細胞過程を調節する重要なエウカリオットの翻訳後の変化である.
- 従来のユビキチン化には,ユビキチン (Ub) のリジン結合が含まれます.
- Legionella pneumophila SidEエフェクターファミリーは,セリン残留を標的としたユニークなフォスフォリボシルユビキチン化 (PR-Ub) 経路を使用しています.
研究 の 目的:
- SdeA触媒モジュールの結晶構造を決定する.
- フォスフォリボシル結合ユビキチネーションの分子メカニズムを解明する.
- SDEA内の異なる機能ユニットの役割を調査する.
主な方法:
- SdeAとSdeDの断片のX線結晶学
- 酵素の活性を分析する生化学分析
- 酵素基板複合体の構造分析
主要な成果:
- SdeA触媒モジュールは,フォスフォディエステラーゼとモノ-ADP-リボシルトランスフェラーゼドメインで構成されています.
- SdeAは,UbをADPリボシレートUb (ADPR-Ub) に変換し,PR-Ubを基板に結合するための独立した活動を示しています.
- 結晶構造はADPR-UbをPR-UbとAMPに変換し,その後のセリン結合を明らかにした.
結論:
- この研究は,フォスフォリボシル結合ユビキチン化の分子メカニズムを確立した.
- この研究は,独特の翻訳後の改変の経路についての洞察を提供します.
- この発見は ユカリオットにおける この異常なユビキチネーションに関する 将来の研究への道を開きます
関連する概念動画
01:27Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
01:29Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K